We have demonstrated that compounds 8c and 13g both bind to Hsp90 in the mid-micromolar range, interfere with the Hsp90–Cdc37 PPI, and exhibit in vitro anticancer activity against Ewing sarcoma, breast cancer, and leukemia cell lines. This evidence concerns the gene HSP90AB1 and Ewing sarcoma.